#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Peritoneal mesothelioma malignant Cardiac amyloidosis Cervix carcinoma Penile squamous cell carcinoma Acute lymphocytic leukaemia recurrent Restless legs syndrome Kidney transplant rejection Aicardi-Goutieres syndrome Myelodysplastic syndrome with excess blasts Phenylketonuria Immune-mediated myositis Langerhans cell sarcoma Osteomyelitis Neuroendocrine tumour Biliary neoplasm More trials…

    Learn about Rare Diseases

    Von Willebrand’s disease – Basic Information Synovial sarcoma metastatic – Treatment Niemann-Pick disease – Treatment Hyperoxaluria – Trials in Disease Hereditary motor and sensory neuropathy – Diagnostics CADASIL – Treatment Haemophilia A with anti factor VIII Myelodysplastic syndrome with excess blasts – Treatment Nephrotic syndrome Haemophilia B without inhibitors More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fluoroethyltyrosine F-18 Tx200-Tr101 Clonazepam Posdinemab AZD6234 Agomelatine Difelikefalin TIL CELLS Io102 Hydrochloride Aflibercept Ecopipam Hydrochloride Naltrexone Hydrochloride INSULIN DETEMIR 6QC-ICG Atomoxetine Hydrochloride Tropicamide Leflunomide Terbinafine Meglumine Gadoterate Noradrenaline Tartrate More therapies…

    Learn about Your Condition

    Laryngeal leukoplakia Choreoathetosis Oesophageal food impaction Pneumothorax Tertiary adrenal insufficiency Fragile X syndrome Psychotic disorder Chronic disease Oedema Pulmonary sarcoidosis Breast cancer metastatic Leiomyosarcoma Postoperative wound infection Endometriosis Vesicoureteric reflux More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Comparing Anakinra versus Immunoglobulin for Treatment-Resistant Kawasaki Disease in Patients Who Failed Initial Immunoglobulin Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Kawasaki’s disease
    Investigated Drugs:
    • Anakinra
    • Human Normal Immunoglobulin
    France

  • Study of Pembrolizumab, Dendritic Cell Vaccine, Trifluridine/Tipiracil, and Bevacizumab for Patients with Metastatic Colorectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Autologous Tumor Lysate-Loaded Dendritic Cells
    • Tipiracil Hydrochloride
    • Trifluridine
    Italy

  • Study on the Effectiveness of Oxaliplatin or Gemcitabine Chemotherapy in Patients with Resected Pancreatic Cancer Using Standard or Genetic Allocation Methods

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Fluorouracil
    Germany Sweden

  • Study of Amoxicillin-clavulanic acid, Piperacillin-tazobactam and Meropenem dosing in critically ill children with systemic infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Amoxicillin Sodium
    • Clavulanic Acid
    • Linezolid
    Belgium

  • Study on Ifosfamide and Doxorubicin for Patients with High-Grade Soft Tissue Sarcoma in the Limbs and Trunk Wall

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • Doxorubicin Hydrochloride
    • Ifosfamide
    Norway

  • Comparison of Short vs Long-term Hormone Therapy with Goserelin, Leuprorelin, or Triptorelin Combined with Radiation for Prostate Cancer Patients After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Bicalutamide
    • Goserelin Acetate
    • Triptorelin
    Spain
Previous Page
1 … 408 409 410 411 412 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!